Risk of progression and dying of clinically localized prostate cancer in Japan

World Journal of Urology

Volumn 14, Issue 6, 1996, Pages 363-369

  Egawa, S ^a   Satoh, T K ^a   Suyama, M ^a   Iwamura, ^a   Uchida, T ^a   Koshiba, K ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; FOLLOW UP; HUMAN; JAPAN; LIFE EXPECTANCY; MALE; MORTALITY; PATHOLOGY; PROSTATE TUMOR;

AGED; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; JAPAN; LIFE EXPECTANCY; MALE; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 0030333755     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00183116     Document Type: Article

References (20)

1. Adolfsson J, Steineck G, Whitmore WF Jr (1993) Recent results of management of palpable clinically localized prostate cancer. Cancer 72:310-322
2. Bilgrami S, Greenberg BR (1994) Why so many operations for localised prostate cancer? Lancet 344:700-701
3. Catalona WJ (1994) Conservative management of prostate cancer (letter). N Engl J Med 330:1830-1831
4. Chodak GW, Thisted RA, Gerber GS, Johansson J-E, Adolfsson J, Jones GW, Chisholm GD, Moskovitz B, Livne PM, Warner J (1994) Results of conservative management of clinically localized prostate cancer. N Engl J Med 330:242-248
5. Egawa S, Shoji K, Go M, Uchida T, Kuwao S, Koshiba K (1993) Long-term impact of conservative management on localized prostate cancer. Urology 42:520-527
6. Egawa S, Suyama K, Ohori M, Kawakami T, Kuwao S, Hirokado K, Hirano S, Yokoyama E, Uchida T, Koshiba K (1995) Early detection of prostate cancer-results of a prostate specific antigen-based detection program in Japan. Cancer 76 : 463-472
7. Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE, for the Prostate Patient Outcomes Research Team (1993) A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 269:2650-2658
8. Gehan E ( 1965) A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203-224
9. Gleason DF ( 1977) Histologie grading and staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologie pathology: the prostate. Lea & Febiger. Philadelphia, pp 171-197
10. Johansson J-E, Andersson S-O (1995) Natural history of primary untreated patients with prostatic carcinoma. Eur Urol [Suppl] 27: 14-15
11. Johansson J-E. Adami H-O, Andersson S-O, Bergstrom R, Holmberg L, Krusemo ÜB (1992) High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 267: 2191-2196
12. Kakizoe T (1993) Figures on cancer in Japan - 1993. Foundation for Promotion of Cancer Research, Tokyo, pp 26-33
13. Kaplan EL. Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-58
14. Meacham RB, Scardino PT, Hoffman GS, Easley JD, Wilbanks JH, Carlton CE Jr ( 1989) The risk of distant metastases after transurethral resection of the prostate versus needle biopsy in patients with localized prostate cancer. J Urol 142: 320-325
15. Scardino PT, Beck JR, Miles BJ (1994) Conservative management of prostate cancer (letter). N Engl J Med 330: 1831
16. Schröder FH, Hermanek P. Denis L, Fair WR, GospodarowicJ. MK, Pavone-Macaluso M (1992) The TNM classification of prostate cancer. Prostate [Suppl] 4: 129-138
17. Statistics and Information Department (1995) Vital statistics 1995 Japan, vol 3. Minister's Secretariat, Ministry of Health and Welfare, Tokyo, pp 100-101
18. Tominaga S, Aoki K, Hanai A, Kurihara N (1993) Cancer statistics - incidence/mortality/prognosis, 1993. Shinohara, Tokyo, pp 154-170
19. Wilt TJ, Brawer MK (1995) The prostate cancer intervention versus observation trial (PIVOT). Cancer 75: 1963-1968
20. Zaridze DO. Boyle P (1987) Cancer of the prostate: epidemiology and aetiology. Br J Urol 59:493-502